EP2625199
Aðferðir til að meðhöndla sóra með því að nota IL-17 mótverkendur
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.10.2011EP published:
22.11.2017EP application number:
11764764.4
EP translation filed:
7.2.2018Grant published:
15.3.2018EPO information:
European Patent Register
Max expiry date:
6.10.2031Expiry date:
6.10.2026Next due date:
31.10.2026
Title:
METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS
Timeline
Today
7.10.2011EP application
22.11.2017EP Publication
7.2.2018Translation submitted
15.3.2018Registration published
6.10.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
GUETTNER, AchimAddress:
Basel, CH
Name:
MACHACEK, MatthiasAddress:
Basel, CH
Name:
PAPAVASSILIS, CharisAddress:
Basel, CH
Name:
SANDER, OliverAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
391388 PDate:
8.10.2010Country:
US
Classification
Categories:
C07K 16/24, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 24.9.2018
Expires: 6.10.2019
Payer: Árnason Faktor
Number: 9
Paid: 23.9.2019
Expires: 6.10.2020
Payer: Árnason Faktor
Number: 10
Paid: 24.9.2020
Expires: 6.10.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 27.9.2021
Expires: 6.10.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 27.9.2022
Expires: 6.10.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 29.9.2023
Expires: 6.10.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 23.9.2024
Expires: 6.10.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 2.10.2025
Expires: 6.10.2026
Payer: Árnason Faktor ehf.